SLI

SLI handeln
2.317,07 PKT +14,79 PKT +0,64 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0QZBF

ISIN CH0030252883


Analysen zu SLI-Werten

Datum Rating Analyst
21.04.05 Novartis Underperform Credit Suisse First Boston
25.04.05 Helvetia Baloise Neutral Sal. Oppenheim
19.04.05 Roche Buy Sarasin Research
19.04.05 Roche Akkumulieren Independent Research
19.04.05 Novartis Neutral JP Morgan
18.04.05 Helvetia Baloise Sector Outperform Vontobel
19.04.05 Roche Overweight JP Morgan
18.04.05 Novartis Outperform Goldman Sachs
18.04.05 Helvetia Baloise Accumulate Helvea
19.04.05 Roche Equal weight Lehman Brothers
18.04.05 UBS Market Perform Vontobel
18.04.05 UBS Market Outperform Vontobel
18.04.05 Nestlé Neutral Sarasin Research
18.04.05 Novartis Neutral HypoVereinsbank
19.04.05 Helvetia Baloise Buy Sarasin Research
15.04.05 Roche In-Line Goldman Sachs
15.04.05 Novartis Kaufen Helaba Trust
18.04.05 Roche Buy Helvea
18.04.05 Novartis Neutral Sarasin Research
15.04.05 Roche In-Line Goldman Sachs
18.04.05 Roche Outperform HypoVereinsbank
18.04.05 Roche Buy Sarasin Research
14.04.05 Novartis Reduce UBS
14.04.05 Novartis Reduce UBS
14.04.05 ABB (Asea Brown Boveri) Overweight Lehman Brothers
14.04.05 Roche Halten Helaba Trust
15.04.05 Novartis Underperform Credit Suisse First Boston
15.04.05 Roche Buy SES Research
13.04.05 Lonza Reduce Sarasin Research
13.04.05 Novartis Neutral Sarasin Research
13.04.05 Logitech Neutral Sarasin Research
11.04.05 Givaudan Equal weight Lehman Brothers
11.04.05 Swiss Life Akkumulieren Nord LB
11.04.05 Richemont Buy Sarasin Research
11.04.05 Lonza Overweight JP Morgan
11.04.05 Givaudan Neutral Helvea
11.04.05 Richemont Accumulate Helvea
11.04.05 Zurich Insurance Neutral JP Morgan
11.04.05 Givaudan Underperform HypoVereinsbank
11.04.05 Givaudan Neutral Sarasin Research